$CBDD "We are very pleased to report strong year-over-year revenue growth in the first nine months of 2021, and importantly, year-to-date, we have already surpassed our 2021 revenue guidance of $22 million (USD)," commented Marcel Gamma, CEO. "The Company remains focused on continued growth while simultaneously moving forward on the completion of its GAAP audit required to become a fully reporting issuer with the SEC, which will enable the Company to move beyond the OTC Pink Market where it can provide investors with improved transparency and increased liquidity."